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Quinones (e.g., coenzyme Q, CoQ10) are best known as carriers of electrons and protons during oxidative phosphorylation and photosynthesis.
A myriad of mostly more indirect physical methods, including fluorescence spectroscopy, electron-spin resonance, and nuclear magnetic
resonance, has been used to localize CoQ10 within lipid membranes. They have yielded equivocal and sometimes contradictory results. Seeking
unambiguous evidence for the localization of ubiquinone within lipid bilayers, we have employed neutron diffraction. CoQ10 was incorporated
into stacked bilayers of perdeuterated dimyristoyl phosphatidyl choline doped with dimyristoyl phosphatidyl serine containing perdeuterated
chains in the natural fluid-crystalline state. Our data show CoQ10 at the center of the hydrophobic core parallel to the membrane plane and not, as
might be expected, parallel to the lipid chains. This localization is of importance for its function as a redox shuttle between the respiratory
complexes and, taken together with our recent result that squalane is in the bilayer center, may be interpreted to show that all natural polyisoprene
chains lie in the bilayer center. Thus ubiquinone, in addition to its free radical scavenging and its well-known role in oxidative phosphorylation as
a carrier of electrons and protons, might also act as an inhibitor of transmembrane proton leaks.
D 2005 Elsevier B.V. All rights reserved.Keywords: Coenzyme Q10; Ubiquinone; Neutron diffraction; Lipid membrane; Electron transfer; Proton permeability1. Introduction
Redox-active quinones with long polyisoprenoid chains like
coenzyme Q are ubiquitous in eukaryotes. They fulfill two
established functions as electron/proton carriers in bioenergetic
membranes and as antioxidants [1]. Since all of the organelle
membranes that contain them are exposed to H+ gradients, they
may also serve as inhibitors of H+ leakage [2].
Ubiquinone (CoQ10) is a 50-carbon polyisoprene with a
terminal quinone domain. It is synthesized in all of the
mammalian organelle membranes investigated [3]. It is
essential for ATP synthesis in mitochondria as a carrier of
electrons and protons in oxidative phosphorylation and in other
proton-pumping membranes, presumably by the Q-cycle [4].0005-2728/$ - see front matter D 2005 Elsevier B.V. All rights reserved.
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E-mail address: hauss@hmi.de (T. Hauß).The structurally and functionally very similar plastoquinone is
employed in photosynthetic membrane systems. The function
of the polyisoprenoid domain of CoQ10 is generally assumed to
anchor the quinone to the hydrophobic domain of the bilayer.
Nonetheless, a short aliphatic chain has been shown to suffice
for this purpose in vitro [5].
The localization of CoQ10 within membranes has been the
subject of many studies [6,7]. The studies, using NMR
spectroscopy [5,8,9], fluorescence [10], differential infrared
spectroscopy [11], linear dichroism [12], and differential
scanning calorimetry [13] have concluded with differing and
often conflicting interpretations.
It has recently been established that squalane, an analogue
of squalene, which appears to inhibit proton leakage across
alkaliphile membranes [14], lies in the bilayer center of
phospholipid bilayers [15]. The ‘‘water cluster’’ model [2] for
proton leakage across lipid bilayers suggests that hydrocarbons
in the center of straight chain lipid bilayers may serve as an
inhibitor of proton leakage in addition to any other functions itta 1710 (2005) 57 – 62
http://www
Fig. 1. Diffractograms of the stacked bilayers of dDMPC/dDMPS (9:1 mol
mol) sample at 25 -C with and without protonated ubiquinone at D2O
H2O=100:0 contrast. Up to six orders are visible. In particular, at 100% D2O
content, the diffractogram of the sample containing deuterated lipids and
protonated ubiquinone is dominated by the third order peak.
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inhibit proton leakage in addition to their other biological roles.
Neutron diffraction is ideal and the most direct tool for
localizing molecular building blocks in lipid bilayers. Due to
the large difference in the coherent scattering length b of a
proton (bH=3.74 fm) and a deuteron (bD=+6.67 fm) an
ideally isomorphous replacement can be achieved. In this
study, a method is applied in which the membrane constituent
CoQ10 is protonated and the bilayer lipids are deuterated. Using
this approach we report that CoQ10 is resident in the center of
perdeuterated dimyristoyl phosphatidyl choline (DMPC)
bilayers doped with 5 mol% dimyristoyl phosphatidyl serine
(DMPS) containing perdeuterated chains.
2. Materials and methods
Perdeuterated dimyristoyl phosphatidyl choline (dDMPC, 67 deuterons,
98% purity) and the net negatively charged lipid dimyristoyl phosphatidyl
serine containing perdeuterated chains (dDMPS, 54 deuterons, 98% purity)
were purchased from Avanti Polar Lipids, Alabaster, AL. Non-deuterated
ubiquinone (89% minimum) was obtained from Sigma Chemicals.
2.1. Preparation of stacked bilayers
Chloroform solutions containing dDMPC/dDMPS (9:1 mol/mol) with or
without an additional 5 mol% perprotonated ubiquinone were prepared. The
total lipid weight for each preparation was 10 mg. Oriented samples were
prepared as described [15]. Dry samples were then rehydrated for 24 h at room
temperature in an atmosphere of 98% relative humidity, maintained with a
saturated K2SO4 solution.
2.2. Neutron diffraction
Neutron diffraction measurements were carried out on the membrane
diffractometer V1 at the Berlin Neutron Scattering Center of the Hahn-Meitner-
Institute, Berlin (Germany) with a neutron wavelength of k =0.452 nm in
thermostated aluminum cans at 98% relative humidity. The procedure is
described in detail elsewhere [15]. Briefly, the diffraction intensities where
measured at four different D2O/H2O contrasts (100:0, 80:20, 50:50, and 0:100)
at T =(25T0.1) -C with rocking scans around the expected Bragg position h by
h T2-. Up to 6 orders were detected for each sample. Diffraction patterns of
dDMPC/dDMPS bilayers were examined with or without 5 mol% protonated
ubiquinone. The measured intensities were scaled with the integrated scattering
length of the water layer using the known differences in scattering length of
subsequent D2O/H2O ratios. The D2O/H2O contrast variation also facilitates the
phase assignment [16]. The square roots of the scaled intensities, corrected with
absorption and Lorenz factors, produced the structure factor amplitudes. The
scattering length density profile q(z) is given by:
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where qo is the total scattering length density of the bilayer, F(h) are the scaled
structure factors and d the unit cell length. For more details to evaluate the
localization of labels in biological membranes, see, e.g., [17,18].
3. Results
The rocking scans around the first order peaks display a
mosaicity inferior to 0.5 degrees demonstrating the excellent
quality of the samples. As already reported [19], few small
yellow droplets of ubiquinone are expelled from the lipid
bilayers, but do not disturb the alignment of the membranes./
/Fig. 1 shows the diffraction patterns obtained from the two
samples containing, or not containing, protonated ubiquinone
at 100:0 D2O/H2O contrast. Up to six diffraction orders were
recorded for each sample with pronounced relative intensity
changes between the samples. The measured d-spacing for the
samples were equal to (5.28T0.04) nm for the pure lipid
sample and (5.38T0.04) nm for the lipid sample with the
ubiquinone, respectively, suggesting no change in the mem-
brane thickness. Profiles of the scattering length densities (i.e.,
the membrane profiles) are calculated as the Fourier sum of the
structure factors. The scattering length density profiles for the
deuterated lipid sample with protonated ubiquinone are
illustrated for the various D2O/H2O atmospheres in Fig. 2,
demonstrating the effect of the contrast variation. The unit cell
is chosen so that the midplane of the lipid membrane is in the
center and the water layers are at its outer edges. At 0% D2O,
the contrast between the water layer and the lipid membrane is
largest, reflecting the negative scattering length density (sld) of
H2O (0.561010 cm2) and the positive average scattering
length density of the deuterated lipids at about +5.91010
cm2. At 100% D2O contrast the scattering length densities of
lipids and water nearly match (sld(D2O)=6.331010 cm2)
and the scattering density profile reflects smaller local changes
in this entity. The scattering length density profiles for the two
samples with and without ubiquinone in an atmosphere of
100% D2O are shown in Fig. 3 together with the corresponding
difference density profile. The protonated ubiquinone shows up
as a negative density difference due to the negative scattering
length of the protons. The difference densities between the
samples with and without the ubiquinone for all four measured
contrast ratios are displayed in Fig. 4 and reflect its location in
Fig. 4. Density profiles for all measured D2O/H2O contrasts. The central
minimum in the scattering length density is caused by the protonated
ubiquinone. This position corresponds to the lipid bilayer center. The wavy
features at the outer edges of the density profiles are due to counting statistics
and Fourier truncation errors and reflect the overall error in the membrane
profiles calculated.
Fig. 2. The effect of the contrast variation on the calculated density profiles are
shown in the case of the deuterated lipid membrane containing the protonated
ubiquinone. The decreasing D2O content from 100% to 0% in the water
composition gives rise to a decrease in the scattering length density in the
aqueous layers of the membrane stack. The scattering length density in the
center of the bilayer is not effected in the experimental error limit.
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middle of the lipid bilayer. The experimental noise level due to
counting statistics and Fourier truncation errors are reflected in
the wavy features at the edges of the profiles. An artist view
reflecting our neutron diffraction result is shown in Fig. 5,
ubiquinone (dark gray) with its quinone ring is located in the
center of the lipid bilayer near the terminal methyl groups, with
minimal penetration into the acyl chain region.
4. Discussion
The aim of the present study is the unequivocal determi-
nation of the location of coenzyme Q10 in lipid bilayers, or
more precisely, the orientation and the depth in the membrane
profile. For this, we used the most direct method: neutron
diffraction in combination with H/D contrast, here deuterated
lipids and protonated CoQ10. CoQ10 contains 10 isoprene
units (50 carbons and 80 hydrogens) with a series of ten
hinged planes (double bonds) and a quinone (9 carbons and 9
hydrogens). It needs not remain in an extended conformation,
but may be curled in the membrane structure. Our approach is
different from the ‘‘typical’’ neutron diffraction analysis onFig. 3. Scattering density profile of the dDMPC/dDMPS (90:10 mol%) stacked
bilayers without (lower solid line) or with (dotted line) protonated ubiquinone.
The two minima represent the headgroups in the bilayers cross section. The
trough in the middle is the bilayers center. The results are the Fourier transform
of the structure factors calculated from the diffractogram in Fig. 1. Upper solid
line: ubiquinone distribution calculated as the difference between the two
scattering density profiles shown in the lower part of the figure. The central
minimum reflects the position of the protonated ubiquinone, in the middle of
the unit cell, i.e., in the center of the membrane.stacked lipid membranes wherein the localization of a small
deuterated molecule (or domain) is determined in per-
protonated bilayer lipids. In this study, we localized the per-
protonated ubiquinone in a perdeuterated bilayer; an approach
now possible due to the availability of per-deuterated lipids.
Our neutron diffraction experiments yielded a set of scattering
length density profiles from samples with deuterated lipids
and deuterated lipids plus protonated ubiquinone at a series of
D2O/H2O ratios of the solvent. From the respective difference
density profiles (Fig. 4), the location of ubiquinone is
demonstrated unambiguously in the bilayer center of lipid
membranes in the physiologically relevant fluid-crystalline
state.Fig. 5. An artist view of the lipid membrane with embedded ubiquinone
derived from the neutron scattering density profiles (Fig. 4). The ubiquinone
molecule (dark gray) is sandwiched between the two lipid layers of the
membrane. Its conformation is not necessarily straight but its location is
confined parallel to the membrane plane with only little intrusions into the lipid
acyl chains.
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phospholipid bilayers [15], together with the present data for
CoQ10 show that all polyisoprenes and polyisoprene domains
lie flat in the bilayer center—between the bilayer leaflets. A
careful review of the localization of polyisoprenes, including
especially ubiquinone, lays out the contradictory data that
leaves the question open to theoretical statements at best [7]. It
is important therefore to have our definitive data on the subject.
The incorporation of CoQ10 into the lipid bilayer does not
change the repeat distance of the membrane stack in the
experimental error limit (the increase is only 0.1 nm). This
finding is in accordance with previous X-ray experiments on
DMPC and DPPC membranes in the presence of ubiquinone
[19]. Inspection of the membrane profiles in Fig. 3 suggests that
the membrane thickness does not change, the density minimum at
T1.6 nm does not change its position on the membrane profile.
Taking advantage of our data we have considered the
following molecular description of ubiquinone in phospho-
lipid bilayers. Using the volumetric lipid data of Nagle and
Tristan-Nagle [20] and the neutron scattering length of
elements [21], the neutron scattering length of deuterated
myristoyl (CD2)12–CD3 – the acyl chain of the lipid used
in these experiments – is calculated to bmyr=266.5 fm, with
a volume of 3901024 cm3 we calculate the neutron
scattering length density to 6.81010 cm2. This is to be
compared to the scattering length density of the total
protonated CoQ10, which is estimated to 0.41010 cm2,
using the scattering length of 78.81 fm and an estimated
volume of 20001024 cm3. Incorporation of the protonated
ubiquinone in the perdeuterated lipid matrix would therefore
reduce the scattering length density where it resides. Our
data (Figs. 3 and 4) prove that the polyisoprene domain of
ubiquinone is at the center of the bilayer, i.e., sandwichedFig. 6. Model of the deuterated DMPC bilayer containing the protonated
ubiquinone with a 100% D2O water layer. The different molecular groups of the
lipids are represented by the Gaussian distributions 1,2,3,4, corresponding to
the terminal methyl groups (1), the acyl chains (2), the glycerol backbone (3),
and the phosphatidyl head group (4). The water distribution (5) is calculated by
the difference of the density profiles at 100% and 0% D2O, respectively. The
model Gaussians 1 to 5 with the appropriate calculated scattering length
densities were first fitted to the density profile of the membrane sample without
ubiquinone, by varying the position, width, and amplitude, but keeping the
integral to the calculated scattering length density. The parameters of the model
Gaussian 6 (dotted curve), which describes the ubiquinone distribution, where
then determined by fitting the parameters to the density profile of the membrane
containing protonated ubiquinone, while keeping the parameters of Gaussians 1
to 5 constant.between the two lipid monolayers. From the width of the
difference density feature, one can conclude that the
polyisoprene chain runs predominantly parallel to the
membrane plane. To illustrate the molecular distribution
along the bilayer profile, we construct a model where
molecular groups are represented by Gaussian distributions
(Fig. 6). A comparison of these data with that of squalane
[15] suggests that both polyisoprenes and polyisoprene
domains in general have the same conformation in
straight-chain lipid bilayers: they lie parallel to the
membrane plane in the bilayer center. Thus, this statement
applies to the myriad of polyisoprenes found in natural
membranes. Only the membranes of the archaea lack
straight-chain lipids, which are replaced by diphytanyl
chains and which also contain polyisoprenes such as
squalene [22]. The localization of polyisoprenes in these
bilayers is yet to be established.
4.1. Previous attempts to localize ubiquinone in bilayers
There have been many attempts using indirect measure-
ments to localize ubiquinone in bilayers. Our neutron
diffraction experiments have unequivocally localized its
polyisoprene domain at the bilayer center. Using differential
scanning calorimetry (DSC) to measure the phase transition
temperature Tm, Katsikakis and Quinn [10,23,24] concluded,
that coenzyme Q10 at up to 20 mol% codispersions in
dipalmitoyl phosphatidyl choline (DPPC) lies in the center
of the bilayers. Fluorescence quenching measurements [25]
are also consistent with the conclusion that ubiquinone resides
in the bilayer center. In contrast, Lenaz et al. [26] have
concluded from fluorescence studies, having the fluorophore
at different heights in the bilayer, ‘‘that CoQ analogues
oscillate between the two bilayer surfaces not extending
beyond the glycerol region.’’
Katsikas and Quinn have shown [23], using X-ray
diffraction, that tocopherol, another polyisoprene, thickens
the bilayer, in contrast to the present study for CoQ10. They
suggested on this basis, that tocopherol is in or near the
bilayer center. In contrast, Stidham et al. [19] reported in their
13C NMR study on egg phosphatidylcholine liposomes
containing ubiquinone, a marked effect on the 13C spin
lattice relaxation times of the hydrocarbon chain atoms near
the lipid head groups, but nearly no effect on the atoms
nearest to the bilayer center, suggesting ubiquinone’s location
in the head group region. They concluded that the ubiquinone
is not located preferentially between the monolayers. A more
extensive study was conducted by Cornell et al. [5]. Using
deuterated ubiquinone and examining its 2H NMR quadrupole
coupling they found that the Q10 isoprenoid chain is in a
mobile environment, physically separated from the coopera-
tive motions and orientational constraints of the bilayer lipid
chains. They thus suggested that the Q10 isoprenoid chain
might lie in the center of the bilayer. These investigators also
synthesized a ubiquinone analogue in which the ten isoprene
groups have been replaced by a perdeuterated saturated
tridecyl chain. The 2H NMR quadrupole coupling showed
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phospholipids and that its quinone domain is in the region of
the phospholipid headgroups. Thus two features of straight-
chain lipid bilayers seem to provoke the isoprenes to reside in
the bilayer center. First, the cooperative motions of the chains
in each monolayer are disrupted by intrusion of branched
hydrocarbons within that monolayer. Second, the two mono-
layers are uncoupled so that the lateral cooperative motions
[27] of the phospholipid acyl chains within one monolayer do
not affect the motions of the other. In a recent study using
NMR chemical shift-polarity correlation Afri et al. [9]
concluded that the ubiquinone ring lies in the lipid head
group region but distant from the lipid–water interface and
place a considerable portion of the isoprenoid side chain
parallel to the lipid acyl chains, an interpretation which is not
in line with our neutron diffraction result.
4.2. Implications of CoQ in the bilayer center
CoQ is best known as a carrier of electrons and protons in
mitochondria during oxidative phosphorylation as is the
ubiquinone analog plastoquinone in chloroplasts during pho-
tophosphorylation [28]. As part of the mitochondrial electron
transport chain CoQ transfers electrons from Complex I and II
to Complex III, all embedded in the inner mitochondrial
membrane. To facilitate electron transport, CoQ should be
freely diffusing in its membrane environment to encounter the
binding pockets in the protein complexes involved [6,29]; this
is best if CoQ10 resides in the membrane midplane, as shown
by our investigation.
Ubiquinone is also well known as an antioxidant in
eukaryotes where it has wide distribution throughout many
organelle membranes [30]. Interest has increased in the specific
location of the quinone in the lipid bilayer cross-section with
the emergence of high-resolution structures of the proteins that
bind it [31].
Our data in Figs. 3 and 4 prove that the polyisoprene
domain of ubiquinone, like that of squalane [15], lies in the
bilayer center parallel to the membrane plane. Thus long
polyisoprenes and polyisopranes can be assumed to have such
a residence. Long polyisoprenes include tocopherol, dolichol,
plastoquinone, carotenes, and lycopene.
The presence of these polyisoprenes in the bilayer center
raises a question as to the area occupied by them since they
appear to be restricted to the cleavage plane. Each isoprene
unit based on models and assuming a conformation parallel
to the bilayer plane, occupies about 0.4–0.5 nm2. Since the
isoprene units are sandwiched between the two monolayers
we need only consider the area of one monolayer with an
area of 0.64 nm2 per lipid. Each CoQ10 contains 10 isoprenes
and a quinone ring. Thus, it covers, if it resides as a
monolayer, 4.4–5.5 nm2, or an average of 5 nm2. This
occupies the area of about 8 lipid molecules. Thus a 6 mol%
of CoQ10 is sufficient to provide a full surface coverage of
each monolayer for the total lipids of the bilayer. The
concentration of ubiquinone in biological membranes is
widespread and largest in mitochondria [1]. Using publisheddata with up to 7 nmol CoQ per mg protein [32], the surface
coverage in mitochondria membranes lies between 10% and
30%. Such a calculation suggests that CoQ10 can represent a
serious barrier for, e.g., proton diffusion across the bilayer of,
say, the inner membrane of the mitochondrion. Taken this
together with our localization of both squalane and ubiqui-
none in the bilayer center, suggests, in accordance with the
‘‘water cluster’’ mechanism for proton leakage [2], that these
polyisoprenes may inhibit proton leakage. Such inhibition
would be another biological function for them, in addition to
their role in redox systems as electron/proton carriers and as
antioxidants.
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